Press "esc" to clear
Go to Advanced Search

Showing results

110 of 5458
beforeandafterphotos_vert.jpg

Article ID: 696509

Lethal Prostate Cancer Treatment May Benefit from Combination Immunotherapy

Johns Hopkins Medicine

Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy (BKI) released a study investigating the use of combination checkpoint immunotherapy in the treatment of a lethal form of advanced prostate cancer. The study suggested a genetic subset of prostate cancer may benefit from this form of immunotherapy.

Released:
25-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Norrisetal.jpg
  • Embargo expired:
    25-Jun-2018 9:00 AM EDT

Article ID: 696245

Researchers Identify Brain Cells Responsible for Removing Damaged Neurons After Injury

The Rockefeller University Press

Researchers at the University of Virginia School of Medicine have discovered that microglia, specialized immune cells in the brain, play a key role in clearing dead material after brain injury. The study, which will be published June 25 in the Journal of Experimental Medicine, reveals that microglia gobble up the remnants of injured neurons, which could prevent the damage from spreading to neighboring neurons and causing more extensive neurodegeneration.

Released:
19-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696566

Radiation oncologists urge Congress to protect patient access to cancer care

American Society for Radiation Oncology (ASTRO)

Radiation oncologists from across the United States will visit Capitol Hill tomorrow to urge Congress to support policies that safeguard cancer patients’ access to high-quality, high-value health care. The doctors will meet with Congressional leaders during the 15th annual American Society for Radiation Oncology (ASTRO) Advocacy Day.

Released:
25-Jun-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
27-Jun-2018 7:00 AM EDT
Released to reporters:
25-Jun-2018 7:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Jun-2018 7:00 AM EDT

Article ID: 696560

New Program Advances Technologies and Treatments of Gastrointestinal, Metabolic Ailments

Cedars-Sinai

Cedars-Sinai has launched an initiative to accelerate the development of novel drugs, devices and therapies aimed at improving treatments for patients with gastrointestinal and metabolic diseases. Physician-scientists and others in the Medically Associated Science and Technology (MAST) Program are focusing their research expertise on disorders of the microbiome. This naturally occurring ecosystem of single-cell organisms—including bacteria, fungi, viruses and archaea—lives within the human gut.

Released:
25-Jun-2018 6:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
gutmicrobiome.jpeg

Article ID: 696533

Dynamic Modeling Helps Predict the Behaviors of Gut Microbes

University of Wisconsin-Madison

A new study provides a platform for predicting how microbial gut communities work and represents a first step toward understanding how to manipulate the properties of the gut ecosystem. This could allow scientists to, for example, design a probiotic that persists in the gut or tailor a diet to positively influence human health.

Released:
22-Jun-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696530

‘Flamingo’: High-Powered Microscopy Coming to a Scientist Near You

University of Wisconsin-Madison

A team at the University of Wisconsin has developed a portable, shareable light sheet microscope — an engineering feat that shrinks a tabletop-sized technology down to the weight and dimensions of a suitcase packed for a week’s vacation. The project can be mailed to a lab anywhere in the world, configured remotely by Morgridge Institute for Research engineers, and run one to three months of experiments.

Released:
22-Jun-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
28-Jun-2018 11:00 AM EDT
Released to reporters:
22-Jun-2018 9:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 28-Jun-2018 11:00 AM EDT

Embargo will expire:
25-Jun-2018 4:00 PM EDT
Released to reporters:
22-Jun-2018 7:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jun-2018 4:00 PM EDT

Embargo will expire:
28-Jun-2018 11:00 AM EDT
Released to reporters:
21-Jun-2018 4:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 28-Jun-2018 11:00 AM EDT


Showing results

110 of 5458





Chat now!